Cell and Gene Therapy Catapult (CGT Catapult) has established a consortium to demonstrate how safety tests that detect potentially dangerous undifferentiated residual cells, which can affect product purity, could be applied to cell therapies.
Global life sciences supply chain conference LogiPharma has announced a brand-new series of interactive formats for 2026 under the leadership of incoming event director, Ben Sharples.
Cold Chain Technologies has announced the launch of the EcoFlex 3, an evolution of its shape stable, full-coverage PCM family of EcoFlex reusable shippers.
ITA Group, a US-headquartered company in engagement solutions, has acquired C2events, an award-winning UK-based event management agency specialising in the healthcare and pharmaceutical sectors.
SGS has achieved a "breakthrough" in infectious disease research with the launch of a novel Respiratory Syncytial Virus (RSV) A-strain challenge agent with proven infectivity in preclinical and clinical stage.
Cencora, a global pharmaceutical solutions company, has announced investments to enhance its third-party logistics (3PL) capabilities in the United States and Europe.
At CPHI Frankfurt, we sat down with Peter Bains, MD & CEO of Syngene International, to discuss the company’s recent investments in peptides and antibody–drug conjugates (ADCs) and the broader evolution of integrated development in biologics.
Buckland Group has announced the completion of its acquisition of Becton Dickinson’s (BD) Swindon manufacturing site, establishing Quvara Medical as a new force in high-precision, high-volume contract manufacturing.
IDA Ireland has published a comprehensive new whitepaper, "The Future of Biopharma in Ireland: Unlocking Growth Through Innovation, Investment, and Collaboration."
